-
1 Comment
Hunan Jingfeng Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 4.3% below its 200 day moving average.
From a valuation standpoint, the stock is 62.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.6.
Hunan Jingfeng Pharmaceutical Co.,Ltd's total revenue rose by 8.1% to $372M since the same quarter in the previous year.
Its net income has increased by 69.5% to $-63M since the same quarter in the previous year.
Finally, its free cash flow grew by 30.7% to $-94M since the same quarter in the previous year.
Based on the above factors, Hunan Jingfeng Pharmaceutical Co.,Ltd gets an overall score of 4/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE000000Y11 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Market Cap | 5B |
|---|---|
| PE Ratio | None |
| Target Price | 12.5 |
| Beta | 0.49 |
| Dividend Yield | None |
Hunan Jingfeng Pharmaceutical Co.,Ltd. manufactures and sells chemical drugs and biological agents in China. The company's principal product is sodium hyaluronate injection for use in orthopedics and surgery applications. It also offers ophthalmology and API products, as well as engages in the research and development of anti-tumor, cancer, and cardiovascular drugs; and provides skin care products. In addition, the company provides CDMO/CMO services. The company was founded in 2003 and is headquartered in Shanghai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000908.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
